Citations 1
Correlation of high p95HER2:HER2 ratio with poor outcome in two phase II clinical trials of trastuzumab-treated HER2-positive metastatic breast cancer.
Chumsri, Saranya , Sperinde, Jeff, Liu, Heshan , Moreno‐Aspitia, Alvaro , McLaughlin, Sarah A. , Winslow, John , Petropoulos, Christos J. , Chenna, Ahmed , Bates, Michael, Weidler, Jodi, Lie, Yolanda, Huang, Weidong , Perez, Edith A. , Gligorov, Joseph , Spano, Jean‐Philippe
Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 603-603
